These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 31339778)

  • 21. EpiHope for the Treatment of Pulmonary Arterial Hypertension: Selective versus Nonselective BET Inhibition.
    Pullamsetti SS; de Jesus Perez VA
    Am J Respir Crit Care Med; 2019 Nov; 200(9):1188-1190. PubMed ID: 31419389
    [No Abstract]   [Full Text] [Related]  

  • 22. In Defense of the Nucleus: NUDT1 and Oxidative DNA Damage in Pulmonary Arterial Hypertension.
    Agarwal S; de Jesus Perez VA
    Am J Respir Crit Care Med; 2021 Mar; 203(5):541-542. PubMed ID: 33095993
    [No Abstract]   [Full Text] [Related]  

  • 23. A Novel Peptide for Immunomodulation in Pulmonary Arterial Hypertension.
    Grinnan D; Farkas L
    Am J Respir Crit Care Med; 2019 Jun; 199(12):1460-1461. PubMed ID: 30973752
    [No Abstract]   [Full Text] [Related]  

  • 24. BET Signaling: A Novel Therapeutic Target for Pulmonary Hypertension?
    Chen L; Liu C; Lu W; Wang T
    Am J Respir Crit Care Med; 2020 May; 201(10):1313. PubMed ID: 32032498
    [No Abstract]   [Full Text] [Related]  

  • 25. Adding an important piece to the pulmonary vascular resistance puzzle in pulmonary arterial hypertension.
    Maron BA; Humbert M
    Eur Respir J; 2020 Jul; 56(1):. PubMed ID: 32646896
    [No Abstract]   [Full Text] [Related]  

  • 26. Determining the Architecture of Inflammation in Pulmonary Arterial Hypertension.
    Rajagopal S; Yu YR
    Am J Respir Crit Care Med; 2024 Jan; 209(2):131-133. PubMed ID: 38033319
    [No Abstract]   [Full Text] [Related]  

  • 27. Reply to Chen
    Provencher S; Boucherat O; Berger RMF; Goumans MJ; Bonnet S
    Am J Respir Crit Care Med; 2020 May; 201(10):1313-1314. PubMed ID: 32032495
    [No Abstract]   [Full Text] [Related]  

  • 28. Assessing the cancer hypothesis of pulmonary arterial hypertension: the devil is in the detail.
    Frump AL; Lai YC; Lahm T
    Am J Physiol Lung Cell Mol Physiol; 2020 Jun; 318(6):L1140-L1141. PubMed ID: 32186392
    [No Abstract]   [Full Text] [Related]  

  • 29. IL-6 in pulmonary hypertension: why novel is not always best.
    Toshner M; Rothman A
    Eur Respir J; 2020 Apr; 55(4):. PubMed ID: 32300021
    [No Abstract]   [Full Text] [Related]  

  • 30. Postural changes from ventilatory gas exchange in pulmonary hypertension: Is it a practical solution to a complex question?
    Rivera-Lebron BN; Cruz Morel KJ; Risbano MG
    Respirology; 2020 Apr; 25(4):354-355. PubMed ID: 31454132
    [No Abstract]   [Full Text] [Related]  

  • 31. Pulmonary Hypertension Associated With Respiratory Diseases　- Which Patients Should Be Treated With Pulmonary Arterial Hypertension-Targeted Therapies?
    Sakamaki F; Asano K
    Circ J; 2021 Mar; 85(4):343-344. PubMed ID: 33563867
    [No Abstract]   [Full Text] [Related]  

  • 32. Endothelial CFTR dysfunction and its involvement in the pathogenesis of pulmonary arterial hypertension.
    Declercq M; Treps L; Bousfia S; Carmeliet P; Witters P
    Eur Respir J; 2021 Aug; 58(2):. PubMed ID: 34385264
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical application of pulmonary vascular resistance in patients with pulmonary arterial hypertension.
    Deng J
    J Cardiothorac Surg; 2021 Oct; 16(1):311. PubMed ID: 34670595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pulmonary Arterial Hypertension and Sex in the Right Ventricle: It Is an Interesting Picture!
    Thenappan T; Weir EK
    Am J Respir Crit Care Med; 2020 Oct; 202(7):928-929. PubMed ID: 32640166
    [No Abstract]   [Full Text] [Related]  

  • 35. Clarifying the Pulmonary Arterial Hypertension Molecular Landscape Using Functional Genetics.
    Maron BA
    Am J Respir Crit Care Med; 2020 Aug; 202(4):488-490. PubMed ID: 32453600
    [No Abstract]   [Full Text] [Related]  

  • 36. Pulmonary Arterial Hypertension and Specialty Care Centers: We Had a Feeling; Now We Have Data.
    Chakinala MM; Farber HW
    Chest; 2020 Jul; 158(1):28-30. PubMed ID: 32654707
    [No Abstract]   [Full Text] [Related]  

  • 37. Initial triple therapy in pulmonary arterial hypertension: coming of age and rejuvenated.
    Bogaard HJ; Sitbon O
    Eur Respir J; 2021 Jan; 57(1):. PubMed ID: 33509909
    [No Abstract]   [Full Text] [Related]  

  • 38. Know your enemy: understanding the pathophysiology of pulmonary hypertension.
    Shimoda LA
    Am J Physiol Lung Cell Mol Physiol; 2020 May; 318(5):L995-L997. PubMed ID: 32233788
    [No Abstract]   [Full Text] [Related]  

  • 39. DNA-Protein Kinase Catalytic Subunit as a Potential Target for Pulmonary Arterial Hypertension.
    Yamamoto K; Lemay SE; Yokokawa T; Breuils-Bonnet S; Salem M; Potus F; Provencher S; Boucherat O; Bonnet S
    Am J Respir Cell Mol Biol; 2023 Jan; 68(1):116-119. PubMed ID: 36583621
    [No Abstract]   [Full Text] [Related]  

  • 40. [Research progress on the role of gas signal molecules on pulmonary arterial hypertension].
    Wang MJ; Tang YY; Yu ZX
    Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Jan; 50(1):14-19. PubMed ID: 35045609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.